Christopher Posner

CIK 1748265 · PRESIDENT AND CEO · last filed 2025-03-04

Christopher Posner is a PRESIDENT AND CEO who has filed 23 SEC Form 4 insider transactions across 1 company since 2018. The most recent filing shows the insider sold $2.8K of CARA on Mar 4, 2025. Across all open-market trades the lifetime net is −$427.4K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

23

Lifetime Open-Market Net

-$427.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Tvardi Therapeutics, Inc. (CARA) Delisted PRESIDENT AND CEO 13,109 $15.96 $209.2K -$427.4K 23 2025-03-04

Recent Filings

23 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-03-04 Tvardi Therapeutics, Inc. (CARA) Delisted Sell (S) −583 -$2.8K EDGAR
2025-02-06 Tvardi Therapeutics, Inc. (CARA) Delisted Sell (S) −372 -$1.8K EDGAR
2024-11-06 Tvardi Therapeutics, Inc. (CARA) Delisted Sell (S) −3,668 -$1.1K EDGAR
2024-08-02 Tvardi Therapeutics, Inc. (CARA) Delisted Sell (S) −4,149 -$1.5K EDGAR
2024-05-06 Tvardi Therapeutics, Inc. (CARA) Delisted Sell (S) −3,936 -$3.0K EDGAR
2024-03-04 Tvardi Therapeutics, Inc. (CARA) Delisted Sell (S) −5,834 -$5.2K EDGAR
2024-02-12 Tvardi Therapeutics, Inc. (CARA) Delisted Sell (S) −35,575 -$18.9K EDGAR
2024-02-05 Tvardi Therapeutics, Inc. (CARA) Delisted Mixed +57,519 -$2.7K EDGAR
2023-11-03 Tvardi Therapeutics, Inc. (CARA) Delisted Sell (S) −3,796 -$4.6K EDGAR
2023-08-04 Tvardi Therapeutics, Inc. (CARA) Delisted Sell (S) −4,307 -$13.2K EDGAR
Showing 110 of 23
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.